2714.10
3.34%
BOB Capital Markets Ltd.
Ajanta Pharma (AJP) posted strong Q4 revenue/EBITDA growth of 32%/31% YoY to Rs 6.8bn/Rs 1.7bn.
Ajanta Pharma Ltd. is trading above its 50 day SMA of 2669.0
More from Ajanta Pharma Ltd.
Recommended